Drugs

FDA Approves New Formulation for Ferriprox (Deferiprone) Twice-a-Day Tablets
Actualités

FDA Approves New Formulation for Ferriprox (Deferiprone) Twice-a-Day Tablets

Chiesi Global Rare Diseases, a business unit of Chiesi Farmaceutici S.p.A., today announced that the U.S. Food and Drug Administration (FDA) has approved Ferriprox® (deferiprone) twice-a-day tablets for the treatment…
WEEKLY UPDATE: Developing Vaccinations & Therapeutic Drugs for COVID-19
Publications

WEEKLY UPDATE: Developing Vaccinations & Therapeutic Drugs for COVID-19

All the latest updates of TIF’s Vaccinations & Therapeutic Drugs Guide for COVID-19 gathered in one single document.
Developing Vaccinations & Therapeutic Drugs for COVID-19 (2020)
TIF Publications

Developing Vaccinations & Therapeutic Drugs for COVID-19 (2020)

TIF has compiled a list of studies/clinical trials for developing drugs and vaccines for the COVID-19 Pandemic, which is by no means exhaustive as research in this area is dramatically…
Bouton retour en haut de la page
Fermer
Fermer